Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Mesut Seker"'
Autor:
Atakan Topcu, Ayse Irem Yasin, Mehmet Besiroglu, Zehra Sucuoglu Isleyen, Zeynep Alaca Topcu, Melih Simsek, Haci Mehmet Turk, Mesut Seker, Pinar Soysal
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundGeriatric syndromes may be more common in older cancer patients than in those without cancer. Geriatric syndromes can cause poor clinical outcomes. The Eastern Cooperative Oncology Group Performance Status (ECOG-PS) is often used as a clini
Externí odkaz:
https://doaj.org/article/31f80b2f7d9b4c52a25c88c0c2a51a40
Autor:
Tuba Baydas, Ganime Coban, Mehmet Besiroglu, Melih Simsek, Abdallah TM Shbair, Atakan Topcu, Ayse Irem Yasin, Mesut Seker, Haci Mehmet Turk
Publikováno v:
International Journal of Gastrointestinal Intervention, Vol 12, Iss 2, Pp 69-74 (2023)
Background : : Tumor budding is a negative prognostic factor for many solid malignancies. We investigated the relationship between patients' clinicopathological characteristics and tumor budding, as well as the effect of budding level on prognosis. M
Externí odkaz:
https://doaj.org/article/1110935154814ae4afa34362deafe021
Autor:
Sabin Goktas Aydin, Engin Eren Kavak, Atakan Topcu, Ayberk Bayramgil, Fahri Akgul, Seda Kahraman, Musa Baris Aykan, Yunus Emre Altıntas, Kaan Helvaci, Yuksel Urun, Ahmet Bilici, Mesut Seker, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Ozgur Acikgoz, Irfan Cicin
Publikováno v:
Biomolecules & Biomedicine, Vol 23, Iss 6 (2023)
Regorafenib, an oral multikinase inhibitor, has improved survival in metastatic colorectal cancer (mCRC) patients who have progressed on standard therapies. Our study aimed to evaluate prognostic factors influencing regorafenib treatment and assess t
Externí odkaz:
https://doaj.org/article/307cb5703f46446fb0e16815e2f38f8b
Autor:
Atakan Topcu, Akin Ozturk, Ismail Yurtsever, Mehmet Besiroglu, Ayse Irem Yasin, Haci Mehmet Turk, Mesut Seker
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 6 (2022)
Erlotinib, a tyrosine kinase inhibitor, has been shown to improve the survival of patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer. Sarcopenia is a status with increasing importance in lung cancer, and it may p
Externí odkaz:
https://doaj.org/article/5c0876d388b543e684eda6cb5f9c5d34
Autor:
Melih Simsek, Mehmet Besiroglu, Adem Akcakaya, Atakan Topcu, Ayse Irem Yasin, Zehra Sucuoglu Isleyen, Mesut Seker, Haci Mehmet Turk
Publikováno v:
Irish Journal of Medical Science (1971 -).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e85ab5ebdf07ef2219f5a9a5726a394f
https://doi.org/10.1007/s11845-023-03340-7
https://doi.org/10.1007/s11845-023-03340-7
Autor:
Melih Simsek, Ayse I. Yasin, Mehmet Besiroglu, Atakan Topcu, Zehra Sucuoglu Isleyen, Mesut Seker, Haci Mehmet Turk
Publikováno v:
Journal of Medical Virology. 94:4138-4143
Although vaccination is efficacious and prevents infection in the general population, there is limited data about Coronavirus disease-19 (Covid-19) occurrence after vaccination in cancer patients. It was aimed to evaluate the efficacy of BNT162b2 (Pf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de36c0eb8e9c0c87aaa627878654dc62
https://doi.org/10.1002/jmv.27835
https://doi.org/10.1002/jmv.27835
Autor:
Ismail Yurtsever, Mesut Seker, Alpay Alkan, Haci Mehmet Turk, Dilek Hacer Cesme, Mehmet Ali Gultekin, Mehmet Besiroglu
Publikováno v:
Academic Radiology. 28:S81-S86
Rationale and Objectives We aimed to investigate whether there are any differences in apparent diffusion coefficient (ADC) values obtained from liver metastases due to gastroenteropancreatic neuroendocrine tumors (GEP-NET) and adenocarcinomas. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64916e037ef099a305e097414d413f58
https://doi.org/10.1016/j.acra.2020.10.024
https://doi.org/10.1016/j.acra.2020.10.024
Autor:
Zehra Sucuoglu, Haci Mehmet Turk, Abdallah T M Shbair, Melih Simsek, Atakan Topcu, Ayse Irem Yasin, Mesut Seker, Zuhal Gucin, Mehmet Besiroglu, Ismail Yurtsever
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:242-246
Introduction Breast cancer is the most frequently diagnosed cancer in women worldwide. Ribociclib is now frequently used in the treatment of metastatic hormone-positive and human epidermal growth factor receptor 2 (HER 2)-negative breast cancer. Case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4099fdde2275d2c40e62888e64492fd
https://doi.org/10.1177/10781552211027931
https://doi.org/10.1177/10781552211027931
Autor:
Melih Simsek, Altay Aliyev, Tuba Baydas, Mehmet Besiroglu, Tarik Demir, Abdallah TM Shbair, Mesut Seker, H. Mehmet Turk
The prognosis of breast cancer patients with brain metastasis is poor. It was aimed to define the clinicopathological features of breast cancer patients with brain metastases and to determine the risk factors and survival outcomes associated with bra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c18dda454506cdd55a810d9a1106b4f
http://hdl.handle.net/20.500.12645/30953
http://hdl.handle.net/20.500.12645/30953
Autor:
Sabin Goktas Aydin, Burcin Cakan Demirel, Ahmet Bilici, Atakan Topcu, Musa Barış Aykan, Seda Kahraman, Ilgın Akbıyık, Muhammed Mustafa Atci, Omer Fatih Olmez, Arzu Yaren, Mehmet Ali Nahit Sendur, Caglayan Geredeli, Mesut Seker, Yuksel Urun, Nuri Karadurmus, Ahmet Aydin
Publikováno v:
Current medical research and opinion. 38(10)
Objectives: Advanced-stage biliary tract cancers (BTC) are rare malignancies with poor prognosis. There are few prospective trials, but several retrospective studies regarding treatment options. In this study, we aimed to investigate the role of syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c95409ebd82240f46af9a150505557
https://pubmed.ncbi.nlm.nih.gov/35916475
https://pubmed.ncbi.nlm.nih.gov/35916475